What is the Future Scope of Biosensors Market amidst COVID-19?

Northbrook, USA, 2020-Apr-15 — /EPR Network/ —

The ongoing COVID-19 pandemic—and the worldwide reaction to it – has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.

At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Biosensors Market. We are working diligently to help companies take rapid decisions by studying:

• The impact of COVID-19 on the Biosensors Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market
• The rapid shifts in the strategies of the Top 50 companies in the Biosensors Market.
• The shifting short-term priorities of the top 50 companies’ clients and their client’s clients

You can request an in-depth analysis detailing the impact of COVID-19 on the Biosensors Market:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=798

The Report “Biosensors Market by Type (Sensor patch and embedded device), Product (Wearable and nonwearable), Technology (Electrochemical and optical), Application (POC, Home Diagnostics, Research Lab, Food & Beverages), and Geography – Global Forecast to 2024″, is expected to grow from USD 21.2 billion in 2019 to USD 31.5 billion by 2024, at a CAGR of 8.3%. Factors such as continuous technological advancements in biosensors ecosystem, increase in the use of biosensors for nonmedical applications, lucrative growth in POC diagnostics, and rise in demand for glucose monitoring systems are driving the growth of the biosensors market.

Embedded device held larger size of biosensor market during forecast period

The growth of embedded devices is attributed to its implementation in environment monitoring, biodefence, and food & beverages to detect and remove contaminants, whether nonliving or living entities. These biosensors can be used for the detection of a broad spectrum of biological analytes and have shown greater responses and success in medical laboratories, food bioanalysis, and microbial detection. Detection of lower or higher limits of glucose in body, microbial invasion in body and food, heavy metals detection in soil and water, air-borne microbes and pesticides in water and soil, and various harmful chemicals produced by body can be easily and timely monitored with precision using the different types of embedded biosensors.

Wearable segment to grow at higher CAGR during forecast period

Wearable biosensors can be considered as among the major developments in healthcare technology. Wearable devices monitoring health consist of different types of miniature biosensors capable of measuring physiological parameters, such as vital signs (heart rate, respiration rate, body and skin temperature, and oxygen saturation), skin conductance, blood pressure, electrocardiogram (ECG), electroencephalography (EEG), acceleration, and rotation.

North America held largest size of biosensors market in 2019

North America held the largest size of the biosensor market in 2019. PoC diagnostics is the fastest-growing application for biosensors in North America. The growth is attributed to the increase in addressable patient population. According to the American Medical Association and American Medical Group Association, more than 50% of Americans were living with one or more chronic diseases until 2012. The number of Americans suffering from chronic diseases was about 125 billion in 2000, which is expected to reach ~157 billion by 2022. The baby boomer population is witnessing a growth in incidences of chronic and infectious diseases. According to the US Census Bureau, the number of individuals over the age of 65 was 39.6 billion in 2009, which is expected to reach 72.1 billion by 2030.

Inquiry Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=798

Key players operating in the biosensor market include Abbott Point of Care Inc. (US), Medtronic Inc. (US), LifeScan Inc. (US), Universal Biosensors Inc. (Australia), F. Hoffman-La Roche Ltd. (Switzerland), DuPont (US), Sysmex Corporation (Japan), Bio-Rad laboratories Inc. (US), Pharmaco-Kinesis Corporation (PKC) (US), Nova Biomedical Corp. (US), ACON Laboratories, Inc. (US), LifeSensors Inc. (US), Biacore (Sweden), and Biosensors International Pte. Ltd. (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com